Skip to main content

Medline Inc.

corporate_fare Company Profile

Medline Inc.

MDLN·NASDAQ·Industrial Applications And Services·CIK 0002046386

General Medline Inc. is the largest provider of medical-surgical (med-surg) products and supply chain solutions, serving all points of care based on total net sales of med-surg products. Founded in 1966, Medline delivers essential products used daily in various healthcare settings, including hospitals, surgery centers, physician offices, and post-acute facilities. The company aims to improve healthcare operations by enhancing clinical, financial, and operational outcomes. Medline operates through two reportable segments: Medline Brand and Supply Chain Solutions. Both segments are supported by a Prime Vendor model, a distinct distribution network, and a strong commercial platform. Through its two segments, Medline offers approximately 335,000 med-surg products, such as surgical and procedural kits, gloves, protective apparel, urological and incontinence care items, wound care products, and consumable lab and diagnostics products. These products are distributed via a global network of distribution facilities and the company's owned fleet of MedTrans trucks. As of December 31, 2025, the Medline Brand segment offers approximately 190,000 med-surg products and holds leading positions in many key product families. Medline Brand products are categorized into three areas: Front Line Care, Surgical Solutions, and Laboratory and Diagnostics. Front Line Care includes wound care, exam gloves, skin care, incontinence products, cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and infection control products. Surgical Solutions provides operating room and perioperative products like surgical procedure trays, drapes, gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Laboratory and Diagnostics offers point-of-care testing, analyzers, instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products.

Medline Inc. (NASDAQ:MDLN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 36 items for MDLN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-13, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for MDLN spans 8-K, 4, 424B4, S-1MEF.

Recent high-impact activity:

  • FDA Flags Medline Kits Over Contaminated BD Applicators
  • Medline Q2 Profit Plunges 58% on $336M Fire Charge, Cuts EBITDA Outlook
  • Medline Q2 Sales Surge 11.6% but Net Income Plunges 58% on Fire Loss; Guidance Mixed
  • Medline COO Stephen Miller to Retire for Health Reasons, Successor Search Underway
  • Medline Secures Prime Vendor Agreement with Allina Health

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$28.43B
Net Income
$1.16B
Diluted EPS
-$0.01
Op. Cash Flow
$1.74B
Free Cash Flow
$1.3B
Gross Profit
$7.52B
Operating Income
$2.21B
Cash & Equivalents
$1.94B
Total Debt
$12.56B
Debt / Equity
0.65×
Net Margin
4.1%
Shares Outstanding
810M sh
Source: 10-K · filed 2026-02-25 · accession 0002046386-26-000009

Dilution Risk

Low risk

Filing-implied dilution signals for MDLN, detected from its recent SEC filings · based on capital-structure filings through 2026-05-26.

1 recent capital raise1 shelf registration

Secondary Offering Finalized · No Proceeds to Company

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with M →
$33.6 -0.83% today
52-week range · as of 2026-08-05 $32.81 – $50.88
Market cap
$45.27B
Volume
10.4M (1.4× avg)
3-mo avg 7.5M
Live data · 2026-09-22 22:29 UTC · After hours

show_chartPrice Chart

Loading chart...

feed MDLN - Latest Insights

MDLN
Aug 13, 2026, 2:00 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $36.08
Real-time Price: $33.60 info
Change: -$2.48 (-7%) info
Market Cap: $45.265B info
MDLN
Aug 05, 2026, 7:42 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $38.00
Real-time Price: $33.60 info
Change: -$4.40 (-12%) info
Market Cap: $45.265B info
MDLN
Aug 05, 2026, 7:34 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $38.00
Real-time Price: $33.60 info
Change: -$4.40 (-12%) info
Market Cap: $45.265B info
MDLN
Jul 09, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $40.85
Real-time Price: $33.60 info
Change: -$7.25 (-18%) info
Market Cap: $45.265B info
MDLN
Jul 08, 2026, 3:29 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $40.51
Real-time Price: $33.60 info
Change: -$6.91 (-17%) info
Market Cap: $45.265B info
MDLN
Jul 02, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $41.73
Real-time Price: $33.60 info
Change: -$8.13 (-19%) info
Market Cap: $45.265B info
MDLN
Jun 03, 2026, 9:36 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $33.37
Real-time Price: $33.60 info
Change: +$0.229 (+0.69%) info
Market Cap: $45.265B info
MDLN
Jun 02, 2026, 8:06 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $35.94
Real-time Price: $33.60 info
Change: -$2.34 (-7%) info
Market Cap: $45.265B info
MDLN
Jun 01, 2026, 6:16 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $35.51
Real-time Price: $33.60 info
Change: -$1.91 (-5%) info
Market Cap: $45.265B info
MDLN
Jun 01, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $35.47
Real-time Price: $33.60 info
Change: -$1.87 (-5%) info
Market Cap: $45.265B info
MDLN
May 29, 2026, 10:44 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $37.12
Real-time Price: $33.60 info
Change: -$3.52 (-9%) info
Market Cap: $45.265B info
MDLN
May 28, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $36.80
Real-time Price: $33.60 info
Change: -$3.20 (-9%) info
Market Cap: $45.265B info
MDLN
May 26, 2026, 4:05 PM EDT
Filing Type: 424B4
Importance Score:
8
Price at Filing: $36.16
Real-time Price: $33.60 info
Change: -$2.56 (-7%) info
Market Cap: $45.265B info
MDLN
May 26, 2026, 4:05 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $36.16
Real-time Price: $33.60 info
Change: -$2.56 (-7%) info
Market Cap: $45.265B info
MDLN
May 21, 2026, 10:47 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $37.16
Real-time Price: $33.60 info
Change: -$3.56 (-10%) info
Market Cap: $45.265B info
MDLN
May 21, 2026, 9:31 PM EDT
Filing Type: S-1MEF
Importance Score:
9
Price at Filing: $37.16
Real-time Price: $33.60 info
Change: -$3.56 (-10%) info
Market Cap: $45.265B info
MDLN
May 20, 2026, 7:11 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $36.06
Real-time Price: $33.60 info
Change: -$2.46 (-7%) info
Market Cap: $45.265B info
MDLN
May 20, 2026, 7:01 AM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $36.69
Real-time Price: $33.60 info
Change: -$3.09 (-8%) info
Market Cap: $45.265B info
MDLN
May 06, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $41.80
Real-time Price: $33.60 info
Change: -$8.20 (-20%) info
Market Cap: $45.265B info
MDLN
May 06, 2026, 2:11 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $41.57
Real-time Price: $33.60 info
Change: -$7.97 (-19%) info
Market Cap: $45.265B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets